Puma Biotechnology (PBYI) reported top line results from the Phase III clinical trial of the company's investigational drug PB272 (neratinib) for the extended adjuvant treatment of breast cancer

Boston Limited is proud to present its ultra-low power ARM®-based server, the Boston Viridis, for the first time in the UK at IP EXPO 2012, Earls Court 2. Visit Boston on stand F14 for a live demonstration.